Skip to content

Clinical trials

Phase 3 Cataract trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cataract Phase: Phase 3 Country / region: United States Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20053
20066
20071
20082
20092
20105
20113
20123
20132
20145
20153
20162
20181
20191
20204
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch & Lomb Incorporated14
Alcon Research9
Omeros Corporation3
Abbott Medical Optics2
Glaukos Corporation2
ICON Bioscience Inc2
Kala Pharmaceuticals, Inc.2
Salvat2
SpyGlass Pharma, Inc.2
Xigen SA2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cataract49
Inflammation15
Pain12
Glaucoma5
Macular Degeneration2
Ocular Hypertension2
Aphakia1
Bone Diseases, Metabolic1
Endophthalmitis1
Eye Infections1

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.